System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gauthier Decanter is an expert in Oncology at Centre Oscar Lambret (France). Gauthier Decanter has authored 36 publications, the most recent in 2025, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 90 (community average: 125). How the SLR is computed.

LeadR Profile

Gauthier Decanter Centre Oscar Lambret France
90 ScienceLeadR Reputation 90

Unlock

Register Login
Network Map

Oncology

Subspecialties: Surgery - Dermatology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2016 - 2025
Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 36

Citations

Citations: 650 1st author: 2 Last author: 3 Unique author: 0

Main journals

Ann Oncol 4
Ann Surg Oncol 4
Bull Cancer 4
Eur J Cancer 3
Acta Oncol 2

Best Journals

J Clin Oncol 2
Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database.
PMID 40961809 — hemangiosarcoma, neoplasms, biopsy, sarcoma, prognosis, dermatofibrosarcoma		Eur J Cancer20250
[Supervision of surgical oncology students in the era of second cycle reform: Active pedagogy implemented].
PMID 40914631 — surgical oncology, neoplasms		Bull Cancer20250
Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registry.
PMID 40799506 — registries, liposarcoma, incidence, neoplasms, pathology, sarcoma, aged, work, sex, prognosis		Lancet Reg Health Eur20252
What is the primary cause of postoperative death after primary retroperitoneal sarcoma surgery in a high-volume center? A nationwide study by the French Sarcoma Group.
PMID 40347715 — mortality, hemorrhage, cause of death, sarcoma, risk factors, morbidity, medical oncology, ischemia		Eur J Surg Oncol20250
[Neoadjuvant imatinib treatment of locally advanced gastrointestinal stromal tumours: Theory and practice].
PMID 40628553 — neoplasms, therapeutics		Bull Cancer20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy
NCT05944913 — radiotherapy, skin, negative-pressure wound therapy, surgical wound, sarcoma, therapeutics, tissues, environment, infections, medical devices		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS